Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Cantor Fitzgerald Starts Korro Bio Inc. (KRRO) at Overweight
-
Western Digital Corp. (WDC) PT Lowered to $50 at Cantor Fitzgerald
-
Seagate Technology (STX) PT Lowered to $100 at Cantor Fitzgerald
-
Teradyne (TER) PT Lowered to $90 at Cantor Fitzgerald
-
NXP Semiconductors NV (NXPI) PT Lowered to $225 at Cantor Fitzgerald
-
Cantor Fitzgerald Reiterates Overweight Rating on CrowdStrike Holdings (CRWD)
-
Cantor Fitzgerald Reiterates Overweight Rating on CG Oncology (CGON)
-
Cantor Fitzgerald Reiterates Overweight Rating on Travere Therapeutics (TVTX)
-
Cantor Fitzgerald Reiterates Overweight Rating on Taysha Gene Therapies (TSHA)
-
Cantor Fitzgerald Reiterates Overweight Rating on Tesla (TSLA)
-
New Providence Acquisition Corp. III Completes $300,150,000 Initial Public Offering
-
Cantor Equity shares rally as retail investors cheer crypto venture
-
Graphene Manufacturing Group Provides Quarterly ATM Sales Update
-
Semler Scientific (SMLR) Announces Updated BTC & ATM Activity
-
Semler Scientific® Announces Updated BTC & ATM Activity; Purchased Additional 111 BTC; Now Holds 3,303 BTC; YTD BTC Yield of 23.5%
-
Alphabet (GOOGL) PT Raised to $171 at Cantor Fitzgerald
-
Inflection Point Acquisition Corp. III Announces Pricing of $220 Million Initial Public Offering
-
Orchid Island Capital Announces First Quarter 2025 Results
-
Cantor Fitzgerald Reiterates Overweight Rating on Molina Healthcare (MOH)
-
Cantor Fitzgerald Reiterates Overweight Rating on CACI International (CACI)
-
Cantor Fitzgerald Reiterates Neutral Rating on Checkpoint Software (CHKP)
-
Cantor Fitzgerald Reiterates Overweight Rating on Lam Research (LRCX)
-
Texas Instruments (TXN) PT Lowered to $170 at Cantor Fitzgerald
-
Cantor Fitzgerald Reiterates Overweight Rating on Impinj Inc (PI)
-
Cantor Fitzgerald Reiterates Overweight Rating on ServiceNow (NOW)
-
Cantor Fitzgerald Reiterates Overweight Rating on CyberArk Software (CYBR)
-
Fortinet (FTNT) PT Lowered to $100 at Cantor Fitzgerald
-
New Providence Acquisition Corp. III Announces the Pricing of $261,000,000 Initial Public Offering
-
Cantor Fitzgerald Reiterates Overweight Rating on aTyr Pharma (ATYR)
-
Cantor Fitzgerald Reiterates Overweight Rating on Travere Therapeutics (TVTX)
-
Cantor teams up with Tether, Softbank for $3.6 billion crypto venture
-
Cantor Fitzgerald Reiterates Overweight Rating on Summit Therapeutics plc (SMMT)
-
Cantor Fitzgerald Reiterates Overweight Rating on Tourmaline Bio (TRML)
-
Tether, SoftBank Group, and Jack Mallers Launch Twenty One, a Bitcoin-native Company, Through a Business Combination With Cantor Equity Partners (CEP)
-
Cantor Fitzgerald Reiterates Overweight Rating on Elevance (ELV)
-
Tether, SoftBank Group, and Jack Mallers Launch Twenty One, a Bitcoin-native Company, Through a Business Combination With Cantor Equity Partners
-
Tesla (TSLA) PT Lowered to $355 at Cantor Fitzgerald
-
Form 424B3 Cantor Fitzgerald Income
-
Cantor nears $3 billion crypto venture with SoftBank and Tether, FT reports
-
H.C. Wainwright & Co., LLC Announces the Hiring of Elemer Piros and Brandon Folkes as Senior Research Analysts, and Expansion of Institutional Sales Team
-
Cantor Fitzgerald Reiterates Overweight Rating on Eli Lilly (LLY)
-
Cantor Fitzgerald Reiterates Overweight Rating on Regeneron Pharma (REGN)
-
Cantor Fitzgerald Reiterates Overweight Rating on Vertex (VRTX)
-
Cantor Fitzgerald Reiterates Overweight Rating on Gilead Sciences (GILD)
-
Cantor Fitzgerald Reiterates Neutral Rating on Amgen (AMGN)
-
Cantor Fitzgerald Reiterates Overweight Rating on Stratasys Inc. (SSYS)
-
Cantor Fitzgerald Assumes Vertex (VRTX) at Overweight
-
Cantor Fitzgerald Assumes Regeneron Pharma (REGN) at Overweight
-
Cantor Fitzgerald Starts Pfizer (PFE) at Neutral
-
Cantor Fitzgerald Starts Vaxcyte (PCVX) at Overweight

